Skip to main content
. 2022 Jan 21;10(2):158. doi: 10.3390/vaccines10020158

Figure 2.

Figure 2

Anti-S1 titers after the second dose in each subgroup of transplant patients. Median optical density of antibody levels in patients with low IgG levels (<600 mg/dL), steroid treatment and low lymphocytes (<1000/μL) was significantly lower than in the other patients. There was no significant difference in S1-antibody titers between the group taking calcineurin inhibitors and the group not taking them (p = 0.45).